Abstract
Purpose
Despite an increasing understanding of the pathology and genetics of non-Hodgkin lymphoma (NHL), global reports on variations in the incidence of NHL remain limited in their number and scope.
Methods
To provide a situation analysis, national incidence estimates for NHL in 185 countries for the year 2018 were obtained from the GLOBOCAN database. We also used recorded incidence data from Cancer Incidence in Five Continents (CI5) plus for years of diagnosis 1980–2012 to examine temporal trends.
Results
NHL ranked as the 5th to 9th most common cancer in most countries worldwide, with almost 510,000 new cases estimated in 2018. Observed incidence rates of NHL 2008–2012 varied markedly by world region: among males, rates were highest among Israel Jews [age-standardized (world) rate of 17.6 per 100,000), Australia (15.3), US whites (14.5), Canada (13.7), and Portugal (13.3)]. Where data were available, most populations exhibited stable or slightly increasing incidence rates; in North America, parts of Europe, and Oceania the rising incidence rates were generally observed until the 1990s, with a stabilization seen thereafter.
Conclusion
Marked variations in NHL incidence rates remain in populations in each world region. Special attention should be given to further etiological research on the role of endemic infections and environmental exposures, particularly in Africa, Asia, and Latin America. To permit internationally comparable statistics, an equal focus on addressing the quality of hematological information in population-based registries is also warranted.
Similar content being viewed by others
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries: global cancer statistics 2018. CA Cancer J Clin. https://doi.org/10.3322/caac.21492
Weltgesundheitsorganisation (2017). WHO classification of tumours of haematopoietic and lymphoid tissues, Revised 4th edn. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (eds) World Health Organization classification of tumours. International Agency for Research on Cancer, Lyon, p 585
Armitage JO, Gascoyne RD, Lunning MA, Cavalli F (2017) Non-Hodgkin lymphoma. Lancet 390(10091):298–310
CRUK (2018) Non-Hodgkin’s lymphoma statistics. 2012. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/non-hodgkin-lymphoma. Accessed 21 Jan 2019
Boffetta P (2011) I. Epidemiology of adult non-Hodgkin lymphoma. Ann Oncol 22(Supplement 4):iv27–iv31
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M et al (2018) Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 391(10125):1023–1075
Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF et al (2014) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr 2014(48):130–144
Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S (2016) Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health 4(9):e609–e616
Shiels MS, Engels EA (2017) Evolving epidemiology of HIV-associated malignancies. Curr Opin HIV AIDS 12(1):6–11
Gibson TM, Morton LM, Shiels MS, Clarke CA, Engels EA (2014) Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study. AIDS 28(15):2313–2318
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012: Globocan 2012. Int J Cancer 136(5):E359–E386
United Nations Development Programme (2017) Human development programme index (HDI). Available from: http://hdr.undp.org/en/content/human-development-index-hdi. Accessed 21 Sept 2018
WHO Global Health Observatory. Available from: http://www.euro.who.int/en/health-topics/disease-prevention/tobacco. Accessed 16 Sep 2018
Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, Ferlay J (eds) (2017) Cancer incidence in five continents, Vol. XI (electronic version). International Agency for Research on Cancer, Lyon. Available from: http://ci5.iarc.fr. Accessed 20 Aug 2018
Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, Ferlay J (eds) (2017) Cancer incidence in five continents plus, (time trends) (electronic version). International Agency for Research on Cancer, Lyon. http://ci5.iarc.fr/CI5plus/Default.aspx. Accessed 22 Sep 2018
WHO. World Health Organization (1995) International statistical classification of diseases and health-related problems - 10th Revision, 2nd edn [Internet]. Available from: http://apps.who.int/classifications/icd10/browse/2010/en. Accessed 17 May 2017
Segi M (1960) Cancer mortality for selected sites in 24 countries (1950–1957). Tohoku University School of Medicine, Sendai
Jensen OM, International Agency for Research on Cancer, World Health Organization, International Association of Cancer Registries (eds) (1991) Cancer registration: principles and methods, IARC scientific publications. International Agency for Research on Cancer, Lyon, p 288
R Development Core Team. R Development Core Team (2014) R: a language and environment for statistical computing (computer programme). R Foundation for Statistical Computing, Vienna
Østgård LSG, Nørgaard M, Nørgaard JM, Severinsen MT, Sengeløv H, Friis LS et al (2013) Data quality in the Danish national acute leukemia registry: a hematological data resource. Clin Epidemiol 5:335
McKay P, Fielding P, Gallop-Evans E, Hall GW, Lambert J, Leach M et al (2016) Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma. Br J Haematol 172(1):32–43
Eichenauer DA, Thielen I, Haverkamp H, Franklin J, Behringer K, Halbsguth T et al (2014) Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin study group. Blood 123(11):1658–1664
IARC. IARC (1997) Epstein–Barr virus and Kaposi’s sarcoma herpesvirus/human herpesvirus 8. World Health Organization, Lyon. Available from: https://monographs.iarc.fr/iarc-monographs-volume-100b-epstein-barr-virus/. Accessed 10 Jan 2019
Weltgesundheitsorganisation, Swerdlow SH, International Agency for Research on Cancer (eds) (2008) WHO classification of tumours of haematopoietic and lymphoid tissues: [… reflects the views of a working group that convened for an Editorial and Consensus Conference at the International Agency for Research on Cancer (IARC), Lyon, October 25–27, 2007, World Health Organization classification of tumours, 4 edn. International Agency for Research on Cancer, Lyon. p 439
Castillo JJ, Beltran BE, Miranda RN, Young KH, Chavez JC, Sotomayor EM (2016) EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management: EBV+ DLBCL 2016 update. Am J Hematol 91(5):529–537
Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375–2390
Silverberg MJ, Lau B, Achenbach CJ, Jing Y, Althoff KN, D’Souza G et al (2015) Cumulative incidence of cancer among persons with HIV in North America: a cohort study. Ann Intern Med 163(7):507–518
Chaabna K, Bray F, Wabinga HR, Chokunonga E, Borok M, Vanhems P et al (2013) Kaposi sarcoma trends in Uganda and Zimbabwe: a sustained decline in incidence?: trends of KS incidence in Zimbabwe and Uganda. Int J Cancer 133(5):1197–1203
Parkin DM, Garcia-Giannoli H, Raphael M, Martin A, Katangole-Mbidde E, Wabinga H et al (2000) Non-Hodgkin lymphoma in Uganda: a case–control study. AIDS 14(18):2929–2936(
Chihara D, Ito H, Matsuda T, Shibata A, Katsumi A, Nakamura S et al (2014) Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol 164(4):536–545
Engels EA, Cho ER, Jee SH (2010) Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol 11(9):827–834
Kim H, Shin AR, Chung HH, Kim MK, Lee JS, Shim J-J et al (2013) Recent trends in hepatitis B virus infection in the general Korean population. Korean J Intern Med 28(4):413–419
Arisawa K, Soda M, Endo S, Kurokawa K, Katamine S, Shimokawa I et al (2000) Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer 85(3):319–324
Proietti FA, Carneiro-Proietti ABF, Catalan-Soares BC, Murphy EL (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24(39):6058–6068
Perry AM, Diebold J, Nathwani BN, MacLennan KA, Müller-Hermelink HK, Bast M et al (2016) Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the international non-Hodgkin lymphoma classification project. Haematologica 101(10):1244–1250
van Leeuwen MT, Turner JJ, Joske DJ, Falster MO, Srasuebkul P, Meagher NS et al (2014) Lymphoid neoplasm incidence by WHO subtype in Australia 1982–2006: lymphoid neoplasms in Australia 1982–2006. Int J Cancer 135(9):2146–2156
Marcos-Gragera R, Pollán M, Chirlaque MD, Gumà J, Sanchez MJ, Garau I et al (2010) Attenuation of the epidemic increase in non-Hodgkin’s lymphomas in Spain. Ann Oncol 21(Suppl 3):iii90–iii96
Adamson P, Bray F, Costantini AS, Tao M-H, Weiderpass E, Roman E (2007) Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in Europe. Eur J Cancer 43(2):391–401
Clarke CA, Glaser SL (2002) Changing incidence of non-Hodgkin lymphomas in the United States. Cancer 94(7):2015–2023
Acknowledgments
The work reported here was undertaken by Dr. Miranda-Filho during the tenure of an IARC Postdoctoral Fellowship, partially supported by the European Commission FP7 Marie Curie—Actions—People—co-funding regional, national, and international programmes (COFUND). We would like to thank the Directors and staff of the population-based cancer registries worldwide who compiled and submitted their data for the CI5 and GLOBOCAN projects used in this paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Miranda-Filho, A., Piñeros, M., Znaor, A. et al. Global patterns and trends in the incidence of non-Hodgkin lymphoma. Cancer Causes Control 30, 489–499 (2019). https://doi.org/10.1007/s10552-019-01155-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-019-01155-5